Updated Jul 16, 2026 · Last SEC filing 2026-06-03
Fulgent Genetics, Inc. (FLGT) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-03. 4 Form 8-K material event filings were reported by FLGT in the last 90 days. 1 Form 144 notices of proposed sale were filed for FLGT stock. InsiderAlpha tracks every FLGT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001674930 |
|---|
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-06-03 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer | S — Open-market sale | 1.7K | $17.89 | $30K | SEC | |
| Xie Jian | President and COO | S — Open-market sale | 2.1K | $17.89 | $38K | SEC | |
| Hsieh Ming | Chief Executive Officer | F — Tax withholding / forfeiture | 4.4K | $18.09 | $79K | SEC | |
| Kim Paul | CFO and Treasurer | F — Tax withholding / forfeiture | 2.1K | $18.09 | $38K | SEC | |
| Gao Hanlin | Chief Scientific Officer | S — Open-market sale | 945 | $17.60 | $17K | SEC | |
| Xie Jian | President and COO | S — Open-market sale | 1.2K | $17.60 | $21K | SEC | |
| Hsieh Ming | Chief Executive Officer | F — Tax withholding / forfeiture | 2.9K | $17.67 | $52K | SEC | |
| Kim Paul | CFO and Treasurer | F — Tax withholding / forfeiture | 1.2K | $17.67 | $21K | SEC | |
| GROVES REGINA E | Insider | A — Grant or award | 11.1K | $0.00 | — | SEC | |
| Nohaile Michael | Insider | A — Grant or award | 5.6K | $0.00 | — | SEC | |
| Marsh Linda | Insider | A — Grant or award | 11.1K | $0.00 | — | SEC | |
| Xie Jian | President and COO | F — Tax withholding / forfeiture | 4.4K | $16.31 | $71K | SEC | |
| Kim Paul | CFO and Treasurer | F — Tax withholding / forfeiture | 2.7K | $16.31 | $45K | SEC | |
| Gao Hanlin | Chief Scientific Officer | F — Tax withholding / forfeiture | 1.6K | $16.31 | $27K | SEC | |
| Hsieh Ming | Chief Executive Officer | F — Tax withholding / forfeiture | 17.6K | $15.33 | $269K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Fulgent Genetics, Inc. (FLGT). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Gao Hanlin | 3 | $74K |
| Kim Paul | 3 | $103K |
| Xie Jian | 3 | $131K |
| Hsieh Ming | 2 | $132K |
| Nohaile Michael | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in FLGT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live FLGT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.